BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview

Comera Life Sciences Holdings- Warrants (19/05/2027) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CMRAW.

Quarterly EBIT

-$2.18M
14.01% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$9.17M
17.32% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)